ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2281

Epidemiology and Risk of Brain Abscess in Patients with Systemic Lupus Erythematosus in Taiwan: A Nationwide Population-based Study

Ke-Hung Lin1, Tzu-Min Lin1 and Chi-Ching Chang2, 1Taipei Medical University Hospital, Taipei, Taiwan, 2Taipei Medical University, Taipei, Taiwan

Meeting: ACR Convergence 2023

Keywords: Administrative Data, Cohort Study, Epidemiology, Infection, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2257–2325) SLE – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune systemic disorder with high morbidity and mortality. Although CNS infections account for only 0.53–2.25% of all infections in patients with SLE, the mortality rate associated with infections of the central nervous system (CNS) such as meningitis and brain abscess (BA) has been reported to be 26.3–52.2%.However, in spite of increased understanding of SLE, many questions (such as epidemiology and risk factors of BA) remain unanswered. Up to date, no study has specifically examined the risk of BA in patients with SLE.We conducted a nationwide population-based cohort study to determine trends in the incidence, mortality and potential risk factors of brain abscess among patient with SLE in Taiwan from 2006 through 2018.

Methods: We identified systemic lupus erythematosus patients from the National Health Insurance research-oriented database, and compared the incidence rate of brain abscess with that among non-systemic lupus erythematosus controls. A Cox multivariable proportional hazards model was employed to evaluate the risk of BA the systemic lupus erythematosus cohort

Results: We included 11,457 SLE patients and 57,285 non-SLE (mean age 42.36 yr, standard deviation 16.66yr; 85.46 % were women). After a mean follow-up of more than six years, the systemic lupus erythematosus cohort had a significantly higher incidence rate of BA (28.83 vs 3.08 per 100,000 person-years, incidence rate ratio 9.36, p<0.001, Table 1) than that of the control cohort.Kaplan–Meier analysis also revealed a significantly higher cumulative incidence of BA in the SLE patients than in the matched controls (p<0.001; Figure 1). Multivariate Cox regression analysis of the SLE and control cohorts (Table 2) revealed that SLE remained a significant risk factor even after other variables were adjusted (adjusted hazard ratio [HR] 7.33, 95% confidence interval [CI] 3.45~15.58,p<0.001). Cox multivariate proportional hazards analysis revealed heart disease (adjusted HR 4.21, [CI] 1.23~14.44), and receiving a mean prednisolone dose >7.5mg (adjusted HR 23.92, [CI] 2.97~192.44) were independent risk factors for brain abscess in systemic lupus erythematosus patients.

Conclusion: A higher risk of BA was observed in systemic lupus erythematosus patients. Risk factors for BA in the systemic lupus erythematosus cohort included heart disease, and receiving a mean prednisolone dose >7.5mg

Supporting image 1

Figure 1 Cumulative incidences of Brain Abscess SLE and Non-SLE population

Supporting image 2

Table 1 Cox regression analysis for the adjusted risk of brain abscess

Supporting image 3

Table 2 Cox regression analysis for the risk of Brain Abscess among systemic lupus erythematosus patients.


Disclosures: K. Lin: None; T. Lin: None; C. Chang: None.

To cite this abstract in AMA style:

Lin K, Lin T, Chang C. Epidemiology and Risk of Brain Abscess in Patients with Systemic Lupus Erythematosus in Taiwan: A Nationwide Population-based Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/epidemiology-and-risk-of-brain-abscess-in-patients-with-systemic-lupus-erythematosus-in-taiwan-a-nationwide-population-based-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epidemiology-and-risk-of-brain-abscess-in-patients-with-systemic-lupus-erythematosus-in-taiwan-a-nationwide-population-based-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology